Additional factors involved in disease have recently been identified, including the proteins TAR DNA binding protein 43 (TDP-43) and fused in sarcoma (FUS) as key players in disease pathogenesis [6], and understanding the molecular mechanisms of ALS will allow the design of effective therapeutics in the future. This evidence concerns the gene FUS and amyotrophic lateral sclerosis.